SHR-A1201
SHR-A1201 is a HER2-targeting antibody-drug conjugate (ADC) . SHR-A1201 is composed of a humanized anti-HER2 antibody (HY-P9907), a linker SMCC (HY-42360), and a microtubulin inhibitor payload Mertansine (HY-19792) . SHR-A1201 can be used for research in HER2-positive breast cancer[1].
Product Specifications
UNSPSC
12352203
Target
Antibody-Drug Conjugates (ADCs) ; EGFR
Type
Reference compound
Related Pathways
Antibody-drug Conjugate/ADC Related; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/shr-a1201.html
Purity
97.35
Smiles
S[R][A1201]
References & Citations
Shipping Conditions
Dry Ice
Storage Conditions
-80°C, protect from light
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-164763/SHR-A1201-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-164763/SHR-A1201-SDS-MedChemExpress.pdf
Badge
Hot
Scientific Category
ADC Related
Clinical Information
No Development Reported
Isoform
ErbB2/HER2
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Lentiviral mouse Hk3 shRNA (UAS) - Lentiviral mouseHk3 shRNA (UAS, GFP) (25)
